Guido Dalbagni, MD


Urologic surgeon Guido Dalbagni – who cares for patients with bladder cancer, kidney cancer, penile cancer, and sarcomas – explains new treatments offered at Memorial Sloan Kettering, which can help patients of any age maintain their quality of life.


I am a urologic surgeon with expertise in the treatment of urologic tumors — which include bladder, urethral, and kidney cancers. I am currently heading clinical trials at Memorial Sloan Kettering to evaluate new therapies for the treatment of high-risk superficial bladder cancer in patients who are resistant to bacillus Calmette-Guérin (BCG) therapy, the standard treatment. I also have expertise in nerve-sparing radical cystectomy followed by bladder reconstruction. I have written a number of articles, and I am on the editorial boards of and a reviewer for several peer-reviewed journals.

Appointments for New Patients
Clinical Expertise

Bladder Cancer; Upper Tract; Urologic Oncology; Kidney Cancer

Languages Spoken

MD, Cairo University Faculty of Medicine (Egypt); MD, University of Parma (Italy)


Cabrini Medical Center (New York); New York University Medical Center


Memorial Sloan Kettering Cancer Center

Board Certifications


See My Colleagues in:
Publications by Guido Dalbagni
Visit PubMed for full listing of Guido Dalbagni journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.